3 Things About CRISPR Therapeutics That Smart Investors Know
The gene-editing virtuoso CRISPR Therapeutics (NASDAQ: CRSP) is one of the most-watched stocks in biotech, and it's no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable hereditary diseases. And if that's not exciting enough, the business is always adding to its treasure trove of valuable biotechnology methods.
Despite the obvious appeal of curing diseases and pioneering new techniques, there's even more to this company than what meets the eye. Let's take a closer look at some of the finer points that skilled investors know about CRISPR.
Image source: Getty Images.
Source Fool.com
